Research facility · founded 1950
Neuropsychiatric Research Institute
Fargo, United States · nrifargo.com
- Citations, last 5 years
- 9
- Works, last 5 years
- 7
- h-index
- 176
- Scientists listed
- 0
- Grants since 2016
- 3
Grants received
2018–2020 · research · R41
Preclinical assessment of the GluN2B inhibitor clinical candidate NP10679 as a medication to prevent opiate abuse relapse
Robert Zaczek · Neuropsychiatric Research Institute · funded by National Institutes of Health
2017–2019 · research · R44
Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage
George Walter Koszalka · Neuropsychiatric Research Institute · funded by National Institutes of Health
2017–2019 · research · R44
Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage
Robert Zaczek · Neuropsychiatric Research Institute · funded by National Institutes of Health